J. Kulhánková

The Association of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Thymidine Kinase, and Tissue Polypeptide Specific Antigen with Outcomes of Patients with Metastatic Colorectal Cancer Treated with Bevacizumab: a Retrospective Study

O. Topolcan, Z. Bortlíček, T. Buchler, 2015, Targeted Oncology.

G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab

O. Topolcan, B. Melichar, Z. Bortlíček, 2016, Tumor Biology.

Nivolumab-induced hepatitis in a patient treated for malignant melanoma

O. Fiala, J. Finek, S. Vokurka, 2020, Onkologie.

Revitalization of Indigenous Culture in Child Care Centre.

J. Kulhánková, 2011 .